Barclays’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
2,534
-47,534
| -95% | -$18.8K | ﹤0.01% | 4286 |
|
|
2025
Q1 | $10K | Buy |
50,068
+7
| +0% | +$1 | ﹤0.01% | 4137 |
|
|
2024
Q4 | $27K | Hold |
50,061
| – | – | ﹤0.01% | 4067 |
|
|
2024
Q3 | $48K | Hold |
50,061
| – | – | ﹤0.01% | 3919 |
|
|
2024
Q2 | $49K | Hold |
50,061
| – | – | ﹤0.01% | 3683 |
|
|
2024
Q1 | $79K | Hold |
50,061
| – | – | ﹤0.01% | 3716 |
|
|
2023
Q4 | $40K | Hold |
50,061
| – | – | ﹤0.01% | 3876 |
|
|
2023
Q3 | $39K | Hold |
50,061
| – | – | ﹤0.01% | 3689 |
|
|
2023
Q2 | $46K | Buy |
+50,061
| New | +$46K | ﹤0.01% | 3711 |
|
|
2022
Q4 | – | Sell |
-340,068
| Closed | -$366K | – | 4363 |
|
|
2022
Q3 | $366K | Buy |
340,068
+87,386
| +35% | +$94.1K | ﹤0.01% | 2754 |
|
|
2022
Q2 | $430K | Buy |
+252,682
| New | +$430K | ﹤0.01% | 2687 |
|
|
2021
Q4 | – | Sell |
-11
| Closed | – | – | 3234 |
|
|
2021
Q3 | $0 | Sell |
11
-38
| -78% | – | ﹤0.01% | 3941 |
|
|
2021
Q2 | $0 | Sell |
49
-8,140
| -99% | – | ﹤0.01% | 4062 |
|
|
2021
Q1 | $43K | Buy |
8,189
+201
| +3% | +$1.06K | ﹤0.01% | 3549 |
|
|
2020
Q4 | $43K | Buy |
7,988
+588
| +8% | +$3.17K | ﹤0.01% | 3226 |
|
|
2020
Q3 | $59K | Hold |
7,400
| – | – | ﹤0.01% | 3213 |
|
|
2020
Q2 | $74K | Hold |
7,400
| – | – | ﹤0.01% | 3242 |
|
|
2020
Q1 | $20K | Buy |
7,400
+6,874
| +1,307% | +$18.6K | ﹤0.01% | 3380 |
|
|
2019
Q4 | $1K | Sell |
526
-1,117
| -68% | -$2.12K | ﹤0.01% | 3803 |
|
|
2019
Q3 | $2K | Buy |
+1,643
| New | +$2K | ﹤0.01% | 3999 |
|
|
2019
Q2 | – | Sell |
-871
| Closed | -$4K | – | 4205 |
|
|
2019
Q1 | $4K | Buy |
871
+600
| +221% | +$2.76K | ﹤0.01% | 4084 |
|
|
2018
Q4 | $2K | Buy |
271
+213
| +367% | +$1.57K | ﹤0.01% | 3899 |
|
|
2018
Q3 | $1K | Sell |
58
-35,053
| -100% | -$604K | ﹤0.01% | 4210 |
|
|
2018
Q2 | $417K | Sell |
35,111
-840
| -2% | -$9.98K | ﹤0.01% | 2386 |
|
|
2018
Q1 | $403K | Buy |
35,951
+851
| +2% | +$9.54K | ﹤0.01% | 2427 |
|
|
2017
Q4 | $234K | Sell |
35,100
-2,500
| -7% | -$16.7K | ﹤0.01% | 2565 |
|
|
2017
Q3 | $308K | Buy |
+37,600
| New | +$308K | ﹤0.01% | 2171 |
|